Mode
Text Size
Log in / Sign up

Oxytocin modulates amygdala activity differently in men and women during emotional stressOxytocin affects the brain's anxiety center differently in men and women

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider sex differences when interpreting oxytocin's effects on amygdala activity in anxiety research.

This meta-analysis synthesized neuroimaging studies examining the effects of oxytocin on amygdala activity in response to negative or stressful emotional stimuli, involving a total of 3337 participants. The primary outcome was modulation of amygdala activity, with secondary outcomes including anxiolytic effects and activity in centromedial and basolateral subregions.

Key findings revealed sex-specific effects: oxytocin significantly inhibited amygdala activity in males but enhanced it in females. In the centromedial subregion, oxytocin reduced activity, while in the basolateral subregion, effects were variable—either decreasing or increasing activity. These results suggest that oxytocin's modulation of amygdala activity is complex and depends on sex and subregion.

The authors note limitations including inconsistent findings across studies due to variabilities in design and populations. Effect sizes, confidence intervals, and p-values were not reported, and safety data were not provided. The practice relevance suggests that individual differences, such as gender, should be considered when developing oxytocin-based therapeutic strategies for anxiety.

How this fits prior evidence

This meta-analysis extends prior coverage of anxiolytic interventions by examining a neurobiological mechanism. While prior coverage highlighted behavioral interventions like Portable Digital Nature Experience and social media reduction for anxiety and loneliness, this work explores oxytocin's neural effects. It contrasts with the lack of causal link between GLP-1R agonists and mental disorders, and adds mechanistic insight beyond preclinical findings on ligustilide. The sex-specific amygdala modulation addresses a gap in understanding individual differences in anxiety treatment.

When we feel anxious or stressed, a part of our brain called the amygdala takes center stage. It helps process emotions like fear and worry. Researchers looked at data from over 3,000 people to see how oxytocin, a hormone often linked to social bonding, affects this specific area.

The results show a striking difference based on gender. In men, oxytocin was found to decrease activity in the amygdala. However, in women, it actually increased activity in that same region. The study also looked at smaller parts of the amygdala, finding that one area showed less activity while another showed mixed results.

Because these findings vary so much by gender, experts suggest that any future treatments using oxytocin must account for individual differences. While the data is complex and some results are inconsistent due to different study methods, it highlights how unique our brains can be when responding to the same substance.

What this means for you:
Oxytocin impacts the brain's fear center differently in men than in women, highlighting the need for personalized care.

Common questions

How does oxytocin affect the brain's response to stress?

Oxytocin affects the amygdala, which is the part of the brain that handles emotional stimuli. The study found that while it can change activity in this region, the results vary significantly based on a person's gender and specific subregions of the brain.

Does oxytocin work differently for men and women?

Yes, the data shows a clear difference. In men, oxytocin was found to inhibit or decrease activity in the amygdala. In contrast, it showed an enhancement effect or increased activity in the amygdala for women.

Is oxytocin a proven treatment for anxiety?

The study shows that oxytocin modulates brain activity related to anxiety, but results are inconsistent across different studies. Because of these variations, doctors must consider individual differences like gender when looking at oxytocin-based strategies.

Study Details

Study typeMeta analysis
Sample sizen = 3,337
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Oxytocin (OT), a neuropeptide essential for social and emotional functions, has been proposed to be anxiolytic as indicated by its effects on inhibiting amygdala activity. However, findings are inconsistent which may be contributed to by variabilities across studies. To obtain a comprehensive overview and a more reliable assessment of the extent to which OT's anxiolytic effects are convergent, we conducted a systematic review and meta-analyses in 55 neuroimaging studies (3337 participants) examining OT's effects on brain responses to negative or stressful emotional stimuli. Results showed a gender-dependent effect of OT on modulating amygdala activity. While OT showed a significant effect on inhibiting amygdala activity in males, an enhancement effect was found in females. An activation likelihood estimation analysis further revealed that OT reduced amygdala activity in the centromedial subregion and could either decrease or increase activity in the basolateral subregion. Our study provides evidence for a gender-dependent anxiolytic effect of OT and its targeting substrates. These findings provide preliminary support for taking individual differences into consideration when developing OT-based therapeutic strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.